Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Prospective study of coffee consumption and risk of Parkinson's disease

European Journal of Clinical Nutrition volume 62, pages 908–915 (2008)Cite this article

Abstract

Objective:

To examine the prediction of coffee consumption on the incidence of Parkinson's disease.

Subjects and methods:

The study population comprised 6710 men and women, aged 50–79 years and free from Parkinson's disease at the baseline. At baseline, enquiries were made about coffee consumption in a self-administered questionnaire as the average number of cups per day. During a 22-year follow-up, 101 incident cases of Parkinson's disease occurred. Parkinson's disease cases were identified through a nationwide registry of patients receiving medication reimbursement, which is based on certificates from neurologist.

Results:

After adjustments for age, sex, marital status, education, community density, alcohol consumption, leisure-time physical activity, smoking, body mass index, hypertension and serum cholesterol, the relative risk for subjects drinking 10 or more cups of coffee per day compared with non-drinkers was 0.26 (95% confidence interval 0.07–0.99, P-value for trend=0.18). The association was stronger among overweight persons and among persons with lower serum cholesterol level (P-value for interaction=0.04 and 0.03, respectively).

Conclusions:

The results support the hypothesis that coffee consumption reduces the risk of Parkinson's disease, but protective effect of coffee may vary by exposure to other factors.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

References

  • Abbott RD, Ross GW, White LR, Nelson JS, Masaki KH, Tanner CM et al. (2002). Midlife adiposity and the future risk of Parkinson's disease. Neurology 59, 1051–1057.

    Article  CAS  Google Scholar 

  • Ajani UA, Willett WC, Seddon JM (1994). Reproducibility of a food frequency questionnaire for use in ocular research. Eye Disease Case–Control Study Group. Invest Ophthalmol Vis Sci 35, 2725–2733.

    CAS  PubMed  Google Scholar 

  • Aromaa A (1981). Epidemiology and public health impact of high blood pressure in Finland. Series AL, no. 17 (in Finnish with an English summary). Social Insurance Institution: Helsinki.

    Google Scholar 

  • Ascherio A, Chen H, Schwarzschild MA, Zhang SM, Colditz GA, Speizer FE (2003). Caffeine, postmenopausal estrogen, and risk of Parkinson's disease. Neurology 60, 790–795.

    Article  CAS  Google Scholar 

  • Ascherio A, Weisskopf MG, O'Reilly EJ, McCullough ML, Calle EE, Rodriguez C et al. (2004). Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Am J Epidemiol 160, 977–984.

    Article  Google Scholar 

  • Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE et al. (2001). Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 50, 56–63.

    Article  CAS  Google Scholar 

  • Bara-Jimenez W, Sherzai A, Dimitrova T, Favit A, Bibbiani F, Gillespie M et al. (2003). Adenosine A(2A) receptor antagonist treatment of Parkinson's disease. Neurology 61, 293–296.

    Article  CAS  Google Scholar 

  • Benedetti MD, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE et al. (2000). Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology 55, 1350–1358.

    Article  CAS  Google Scholar 

  • Cardoso SM, Moreira PI, Agostinho P, Pereira C, Oliveira CR (2005). Neurodegenerative pathways in Parkinson's disease: therapeutic strategies. Curr Drug Targets CNS Neurol Disord 4, 405–419.

    Article  CAS  Google Scholar 

  • Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth Jr WT, Swanson PD (2002). Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 155, 732–738.

    Article  Google Scholar 

  • Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A (2003). Dietary intakes of fat and risk of Parkinson's disease. Am J Epidemiol 157, 1007–1014.

    Article  Google Scholar 

  • Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Willett WC, Ascherio A (2004). Obesity and the risk of Parkinson's disease. Am J Epidemiol 159, 547–555.

    Article  Google Scholar 

  • Cox D (1972). Regression models and life tables. J R Stat Soc B 34, 187–220.

    Google Scholar 

  • de Lau LM, Breteler MM (2006). Epidemiology of Parkinson's disease. Lancet Neurol 5, 525–535.

    Article  Google Scholar 

  • de Lau LM, Koudstaal PJ, Hofman A, Breteler MM (2006). Serum cholesterol levels and the risk of Parkinson's disease. Am J Epidemiol 164, 998–1002.

    Article  Google Scholar 

  • Debry G (1994). Coffee and Health. John Libbey Eurotext: Paris.

    Google Scholar 

  • Erkkola M, Karppinen M, Javanainen J, Rasanen L, Knip M, Virtanen SM (2001). Validity and reproducibility of a food frequency questionnaire for pregnant Finnish women. Am J Epidemiol 154, 466–476.

    Article  CAS  Google Scholar 

  • Fahn S (1991). An open trial of high-dosage antioxidants in early Parkinson's disease. Am J Clin Nutr 53, 380S–382S.

    Article  CAS  Google Scholar 

  • Feskanich D, Rimm EB, Giovannucci EL, Colditz GA, Stampfer MJ, Litin LB et al. (1993). Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 93, 790–796.

    Article  CAS  Google Scholar 

  • Fink J, Bains L, Beiser A, Seshadri S, Wol P (2001). Caffeine intake and the risk of incident Parkinson's disease: The Framingham study. Fifteenth annual symposia abstracts. Mov Disord 16, 984.

    Google Scholar 

  • Hauser RA, Hubble JP, Truong DD (2003). Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD. Neurology 61, 297–303.

    Article  CAS  Google Scholar 

  • Helakorpi S, Patja K, Prättälä R, Aro A, Uutela A (2004). Health Behaviour and Health among the Finnish Adult Population, Spring 2004 (in Finnish with an English summary). National Public Health Institute: Helsinki.

    Google Scholar 

  • Hellenbrand W, Boeing H, Robra BP, Seidler A, Vieregge P, Nischan P et al. (1996). Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case–control study. Neurology 47, 644–650.

    Article  CAS  Google Scholar 

  • Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ (2002). A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 52, 276–284.

    Article  Google Scholar 

  • Huang T, Chen C, Wefler V, Raftery A (1961). A stable reagent for the Lieberman-Burchard reaction. Application to rapid serum cholesterol determination. Anal Chem 33, 1405–1407.

    Article  CAS  Google Scholar 

  • International Coffee Organization (2006). Coffee Market Report May 2006. Letter from the executive director. Available at:http://dev.ico.org/documents/cmr0506e.pdf.Accessed September 1, 2006.

  • Järvinen R (1996). Epidemiological Follow-up Study on Dietary Antioxidant Vitamins. Studies in Social Security and Health 11. Social Insurance Institution: Helsinki.

    Google Scholar 

  • Johnson CC, Gorell JM, Rybicki BA, Sanders K, Peterson EL (1999). Adult nutrient intake as a risk factor for Parkinson's disease. Int J Epidemiol 28, 1102–1109.

    Article  CAS  Google Scholar 

  • Khani BR, Ye W, Terry P, Wolk A (2004). Reproducibility and validity of major dietary patterns among Swedish women assessed with a food-frequency questionnaire. J Nutr 134, 1541–1545.

    Article  CAS  Google Scholar 

  • Knekt P (1988). Serum Alpha-tocopherol and the Risk of Cancer. Series ML, no. 83 Social Insurance Institution: Helsinki.

    Google Scholar 

  • Lang AE, Lozano AM (1998). Parkinson's disease. First of two parts. N Engl J Med 339, 1044–1053.

    Article  CAS  Google Scholar 

  • Natella F, Nardini M, Giannetti I, Dattilo C, Scaccini C (2002). Coffee drinking influences plasma antioxidant capacity in humans. J Agric Food Chem 50, 6211–6216.

    Article  CAS  Google Scholar 

  • Paganini-Hill A (2001). Risk factors for Parkinson's disease: the leisure world cohort study. Neuroepidemiology 20, 118–124.

    Article  CAS  Google Scholar 

  • Ragonese P, Salemi G, Morgante L, Aridon P, Epifanio A, Buffa D et al. (2003). A case–control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease. Neuroepidemiology 22, 297–304.

    Article  CAS  Google Scholar 

  • Rajput AH, Rozdilsky B, Rajput A (1991). Accuracy of clinical diagnosis in parkinsonism – a prospective study. Can J Neurol Sci 18, 275–278.

    Article  CAS  Google Scholar 

  • Reunanen A, Aromaa A, Pyörälä K, Punsar S, Maatela J, Knekt P (1983). The Social Insurance Institution's coronary heart disease study Baseline data and 5-year mortality experience. Acta Med Scand Suppl 673, 1–120.

    CAS  PubMed  Google Scholar 

  • Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH et al. (2000). Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283, 2674–2679.

    Article  CAS  Google Scholar 

  • Schwarzschild MA, Chen JF, Ascherio A (2002). Caffeinated clues and the promise of adenosine A(2A) antagonists in PD. Neurology 58, 1154–1160.

    Article  CAS  Google Scholar 

  • The Parkinson Study Group (1993). Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 328, 176–183.

    Article  Google Scholar 

  • Wirdefeldt K, Gatz M, Pawitan Y, Pedersen NL (2005). Risk and protective factors for Parkinson's disease: a study in Swedish twins. Ann Neurol 57, 27–33.

    Article  Google Scholar 

  • Yen WJ, Wang BS, Chang LW, Duh PD (2005). Antioxidant properties of roasted coffee residues. J Agric Food Chem 53, 2658–2663.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by National Institutes of Health Grants NIH/NIEHS R01 ES012667.

Author information

Authors and Affiliations

  1. National Public Health Institute, Helsinki, Finland

    K Sääksjärvi, P Knekt, H Rissanen, M A Laaksonen, A Reunanen & S Männistö

Authors
  1. K Sääksjärvi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Knekt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Rissanen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M A Laaksonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Reunanen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Männistö
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P Knekt.

Additional information

Contributors: KS participated in the study concept and design, performed data analysis and drafted the paper. PK designed the study concept, coordinated and supervised the conducting of the study, and was closely involved with the interpretation of the results and participated in drafting of the paper. HR maintained the database and advised in performing the data analysis. MAL supervised the use of statistical methods and participated in critical revision of the paper. AR participated in critical revision of the paper. SM designed the study concept and supervised the conducting of the study together with PK, was involved with the interpretation of the results and participated in drafting of the paper and in critical revision of the paper.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sääksjärvi, K., Knekt, P., Rissanen, H. et al. Prospective study of coffee consumption and risk of Parkinson's disease. Eur J Clin Nutr 62, 908–915 (2008). https://doi.org/10.1038/sj.ejcn.1602788

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1602788

Keywords

This article is cited by

Search

Advanced search

Quick links